期刊文献+

2013欧洲泌尿外科学会《男性下尿路症状治疗指南》之解读 被引量:5

Interpretation of 2013 version of the European Association of Urology guidelines on the treatment of male lower urinary tract symptoms
下载PDF
导出
摘要 欧洲2013版《男性下尿路症状治疗指南》拓宽了良性前列腺增生及男性下尿路症状诊疗的传统认识。在诊治下尿路症状时需要将整个尿路作为一个功能单元。关于下尿路症状评估和药物治疗的指南解读,有助于泌尿外科的临床诊治。 The 2013 version of European Association of Urology guidelines broaden the traditional diagnosis and treatment of benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS). When the patients with LUTS are diagnosed and treated, the whole urinary tract needs to be considered as a functional unit. It is valuble for urological surgeons to introduce the interpretation of the guidelines for evaluation and medication of LUTS.
出处 《上海医药》 CAS 2014年第6期7-10,共4页 Shanghai Medical & Pharmaceutical Journal
关键词 前列腺增生 男性下尿路症状 指南解读 prostatic hyperplasia male lower urinary tract symptoms interpretation guide treatment of ofLUTS
  • 相关文献

参考文献18

  • 1Chapple CR, Roehrborn CG. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder[J]. Eur Urol, 2006, 49(4): 651-658.
  • 2Berry S J, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age[J]. J Urol, 1984, 132(3): 474-479.
  • 3Michel MC, Vrydag W. Alphal-alpha2- and beta- adrenoceptors in the urinary bladder, urethra and prostate[J]. Br J Pharmacol, 2006, 147(Suppl 2): S88-119.
  • 4Kortmann BB, Floratos DL, Kiemeney LA, et al. Urodynamic effects of alpha-adrenoceptor blockers: a review of clinical trials[J]. Urology, 2003, 62(1): 1-9.
  • 5Barendrecht MM, Abrams P, Schumacher H, et al. Do alphal-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?[J]. Neurourol Urodyn, 2008, 27(3): 226-230.
  • 6Naslund M J, Miner M. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate[J]. Clin Yher, 2007, 29(1): 17-25.
  • 7Rittmaster RS, Norman RW, Thomas LN, et al. Evidence for atrophy and apoptosis in the prostates of men given finasteride[J]. J Clin Endocrinol Metab, 1996, 81(2): 814-819.
  • 8Andriole G, Bruchovsky N, Chung LW, et al. Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia[J]. J Urol, 2004, 172(4 pt 1): 1399-1403.
  • 9Donohue JF, Sharma H, Abraham R, et al. Transurethral prostate resection and bleeding: a randomized, placebo controlled trial of role of finasteride for decreasing operative blood loss[J]. J Urol, 2002, 168(5): 2024-2026.
  • 10Matsui M, Motomura D, Karasawa H, et al. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype[J]. Proc Natl Acad Sci USA, 2000, 97(17): 9579- 9584.

同被引文献26

引证文献5

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部